Oscar Health, Inc. (NYSE:OSCR) Shares Purchased by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. raised its position in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 39.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 128,167 shares of the company's stock after purchasing an additional 36,577 shares during the quarter. Harbor Capital Advisors Inc. owned 0.05% of Oscar Health worth $1,723,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of OSCR. State Street Corp raised its position in Oscar Health by 6.0% in the third quarter. State Street Corp now owns 5,132,802 shares of the company's stock valued at $108,867,000 after purchasing an additional 291,335 shares during the period. Geode Capital Management LLC grew its stake in shares of Oscar Health by 11.7% in the third quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company's stock valued at $92,062,000 after buying an additional 455,205 shares in the last quarter. Renaissance Technologies LLC raised its holdings in shares of Oscar Health by 31.7% during the 2nd quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company's stock valued at $61,478,000 after buying an additional 934,600 shares during the period. JPMorgan Chase & Co. lifted its position in Oscar Health by 68.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 2,309,150 shares of the company's stock worth $48,977,000 after acquiring an additional 938,742 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Oscar Health by 20.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,600,166 shares of the company's stock worth $33,940,000 after acquiring an additional 270,223 shares during the period. 75.70% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms have recently commented on OSCR. Bank of America cut shares of Oscar Health from a "neutral" rating to an "underperform" rating and reduced their target price for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. Jefferies Financial Group initiated coverage on shares of Oscar Health in a report on Tuesday, December 10th. They issued an "underperform" rating and a $12.00 price objective on the stock. Finally, UBS Group began coverage on Oscar Health in a research note on Monday, October 7th. They set a "neutral" rating and a $23.00 target price for the company. Two analysts have rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $21.56.

Oscar Health Stock Down 0.1 %

Shares of Oscar Health stock traded down $0.02 during trading on Monday, reaching $14.16. The company had a trading volume of 3,127,732 shares, compared to its average volume of 3,311,804. The company has a market cap of $3.50 billion, a price-to-earnings ratio of -235.96 and a beta of 1.70. Oscar Health, Inc. has a fifty-two week low of $10.45 and a fifty-two week high of $23.79. The firm's fifty day moving average is $15.10 and its 200-day moving average is $16.88. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73.

Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same period in the prior year, the business earned ($0.29) EPS. The company's quarterly revenue was up 68.3% on a year-over-year basis. On average, analysts anticipate that Oscar Health, Inc. will post -0.01 EPS for the current year.

Insiders Place Their Bets

In related news, Vice Chairman Joshua Kushner bought 358,619 shares of the stock in a transaction dated Wednesday, November 13th. The stock was bought at an average cost of $13.74 per share, with a total value of $4,927,425.06. Following the completion of the acquisition, the insider now owns 5,810,700 shares of the company's stock, valued at $79,839,018. This trade represents a 6.58 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Steven Wolin sold 19,580 shares of the firm's stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $354,006.40. Following the completion of the sale, the chief operating officer now directly owns 102,598 shares in the company, valued at approximately $1,854,971.84. This trade represents a 16.03 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders acquired 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. 25.11% of the stock is currently owned by corporate insiders.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.